Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

NCT05088343 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Rosuvastatin
DRUG: Hetrombopag

Sponsor

Jiangsu HengRui Medicine Co., Ltd.